BioCryst Pharmaceuticals | BCRX - Dywidenda Wydajność





Dy Zmiana Data
BioCryst Pharmaceuticals 0 0 2025-03
Chugai Pharma 1.42 0.12 2026-03
Daiichi Sankyo 2.06 0.25 2025-12
DBV Technologies USD 0 0 2024-08
Enanta Pharmaceuticals 0 0 2025-03
Gilead Sciences 2.29 0.29 2026-03
GlaxoSmithKline 0.82 3.75 2026-03
Glaxosmithkline GBP 4.47 0.32 2025-12
Karyopharm Therapeutics 0 0 2025-03
Regeneron Pharmaceuticals 0.46 0.01 2026-03
Roche Holding 2.96 0.8 2025-12